Accuracy and user performance evaluation of the Contour® Next Link 2.4 blood glucose monitoring system

被引:10
作者
Bailey, Timothy [1 ]
Wallace, Jane F. [2 ]
Greene, Carmine [2 ]
Pardo, Scott [2 ]
Brown, Daniel [2 ]
Pflug, Brian [2 ]
Klaff, Leslie J. [3 ]
机构
[1] AMCR Inst Inc, Escondido, CA 92025 USA
[2] Bayer HealthCare LLC, Diabet Care, Whippany, NJ 07981 USA
[3] Rainier Clin Res Ctr, Renton, WA 98057 USA
关键词
Self-monitoring of blood glucose; Type; 1; diabetes; 2; INSULIN; THERAPY;
D O I
10.1016/j.cca.2015.06.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The Contour (R) Next Link 2.4 blood glucose monitoring system (BGMS), which communicates wirelessly exclusively with a Medtronic insulin pump, was assessed in 2 separate studies. Methods: In the laboratory study (N = 100), subject capillary fingertip samples were tested in duplicate using 3 test strip lots; accuracy was assessed based on ISO 15197:2013 section 63 accuracy criteria (95% within +/- 15 mg/dl or +/- 15% of reference for glucose <100 and >= 100 mg/dl, respectively). In the clinical trial (N = 219), untrained subjects with diabetes tested capillary fingertip and palm blood samples and completed an ease-of-use questionnaire. BGMS and YSI glucose analyzer results were compared based on ISO 15197:2013 section 8 accuracy criteria. Results: In the laboratory study, 100% of results met ISO 15197:2013 section 6.3 accuracy criteria. In the clinical trial, 98.6% of capillary fingertip and 972% of palm results from subjects met ISO 15197:2013 section 8 accuracy criteria. By Parkes-Consensus Error Grid analysis, 100% of subject capillary fingertip results were within Zone A. Based on questionnaire results, the majority of subjects found the BGMS easy to use. Conclusions: The BGMS exceeds ISO 15197:2013 section 63 and section 8 accuracy criteria in the laboratory and in the hands of untrained users with diabetes. (C) 2015 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 27 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s011, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S011, 10.2337/dc12-s064]
[2]  
[Anonymous], 151972013E ISO
[3]   Evaluation of the performance of a new OptiScanner™ 5000 system for an intermittent glucose monitoring [J].
Barassi, Alessandra ;
Umbrello, Michele ;
Ghilardi, Francesca ;
Damele, Clara Anna Linda ;
Massaccesi, Luca ;
Iapichino, Gaetano ;
d'Eril, Gian Vico Melzi .
CLINICA CHIMICA ACTA, 2015, 438 :252-254
[4]   The clinical performance of the EGV1 self-monitoring blood glucose system [J].
Chen, Chien-Chih ;
Lin, Jui-Jane ;
Hung, Sheng-tien ;
Chun, Peng-Ting ;
Lai, Yiu-Kay .
CLINICA CHIMICA ACTA, 2012, 413 (13-14) :1039-1044
[5]   Insulin pump therapy in adults [J].
Didangelos, Triantafillos ;
Iliadis, Fotios .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 :S109-S113
[6]   Diabetes Ten City Challenge: Final economic and clinical results [J].
Fera, Toni ;
Bluml, Benjamin M. ;
Ellis, William M. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (03) :383-391
[7]   ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial [J].
Franciosi, M. ;
Lucisano, G. ;
Pellegrini, F. ;
Cantarello, A. ;
Consoli, A. ;
Cucco, L. ;
Ghidelli, R. ;
Sartore, G. ;
Sciangula, L. ;
Nicolucci, A. .
DIABETIC MEDICINE, 2011, 28 (07) :789-796
[8]  
Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903
[9]   External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives [J].
Hanaire, H. .
DIABETES & METABOLISM, 2011, 37 :S40-S47
[10]   Glucose meter inaccuracy and the impact on the care of patients [J].
Hellman, Richard .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (03) :207-209